2
Gilead Improves Drug Safety and Supports AI Roadmap with TIBCO Spotfire Enhanced data exploration with real-time analytics CHALLENGE Digital transformation is a continuous process for Gilead, because in its FDA regulated industry, pharmacological research, development, and manufacturing are continuously changing. Life Sciences is evolving, with companies investigating drug side effects and safety more thoroughly. To keep up, Gilead needed an analytics platform that would allow deeper data discovery and intuitive data visualizations. “Our requirement was interactive visualizations that could support exploratory data analysis for a highly regulated environment, and yet meet our futuristic AI pathway and help us embrace open source,” said Vishakha Mujoo, manager of R&D information systems. SOLUTION Several groups within Gilead use TIBCO Spotfire ® analytics for use cases from day-to-day operations monitoring to trend analysis, helping everyone better understand their data. The clinical trials group uses it for statistical analysis; the operations team for daily monitoring of live data to uncover issues faster; the submissions team for trend analysis and live monitoring of submissions; and the MSS group for supporting signal detection. “Spotfire ® analytics is helping integrate various groups, connecting the dots, and making sure we are able to standardize our processes across various functional groups,” said Mujoo. “Our need was not just pretty dashboards but something that would have brains, too, and could help us dig deeper to analyze trends in our data and meet our future AI requirements.” —Vishakha Mujoo, Manager of R&D Information Systems for Pharmacovigilance and Epidemiology

Gilea Improve Dru Safet an Support AI Roadma wit …...R&D information systems. SOLUTION Several groups within Gilead use TIBCO Spotfire ® analytics for use cases from day-to-day

  • Upload
    others

  • View
    5

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Gilea Improve Dru Safet an Support AI Roadma wit …...R&D information systems. SOLUTION Several groups within Gilead use TIBCO Spotfire ® analytics for use cases from day-to-day

Gilead Improves Drug Safety and Supports AI Roadmap with TIBCO SpotfireEnhanced data exploration with real-time analytics

CHALLENGE Digital transformation is a continuous process for Gilead, because in its FDA regulated industry, pharmacological research, development, and manufacturing are continuously changing.

Life Sciences is evolving, with companies investigating drug side effects and safety more thoroughly. To keep up, Gilead needed an analytics platform that would allow deeper data discovery and intuitive data visualizations.

“Our requirement was interactive visualizations that could support exploratory data analysis for a highly regulated environment, and yet meet our futuristic AI pathway and help us embrace open source,” said Vishakha Mujoo, manager of R&D information systems.

SOLUTIONSeveral groups within Gilead use TIBCO Spotfire® analytics for use cases from day-to-day operations monitoring to trend analysis, helping everyone better understand their data. The clinical trials group uses it for statistical analysis; the operations team for daily monitoring of live data to uncover issues faster; the submissions team for trend analysis and live monitoring of submissions; and the MSS group for supporting signal detection.

“Spotfire® analytics is helping integrate various groups, connecting the dots, and making sure we are able to standardize our processes across various functional groups,” said Mujoo.

“Our need was not just pretty dashboards but something that would have brains, too, and could help us dig deeper to analyze trends in our data and meet our future AI requirements.”

—Vishakha Mujoo, Manager of R&D Information

Systems for Pharmacovigilance and Epidemiology

Page 2: Gilea Improve Dru Safet an Support AI Roadma wit …...R&D information systems. SOLUTION Several groups within Gilead use TIBCO Spotfire ® analytics for use cases from day-to-day

SUCCESS STORY | 2

Global Headquarters 3307 Hillview Avenue Palo Alto, CA 94304+1 650-846-1000 TEL +1 800-420-8450 +1 650-846-1005 FAXwww.tibco.com

TIBCO fuels digital business by enabling better decisions and faster, smarter actions through the TIBCO Connected Intelligence Cloud. From APIs and systems to devices and people, we interconnect everything, capture data in real time wherever it is, and augment the intelligence of your business through analytical insights. Thousands of customers around the globe rely on us to build compelling experiences, energize operations, and propel innovation. Learn how TIBCO makes digital smarter at www.tibco.com.©2019, TIBCO Software Inc. All rights reserved. TIBCO, the TIBCO logo, and Spotfire are trademarks or registered trademarks of TIBCO Software Inc. or its subsidiaries in the United States and/or other countries. All other product and company names and marks in this document are the property of their respective owners and mentioned for identification purposes only.

04/30/19

BENEFITSTHE RIGHT DRUG, IN THE RIGHT TIMEUsing the Spotfire solution to identify outliers and patterns in complex, disparate data sources, Gilead enabled early detection of unexpected drug safety problems. With this increased oversight, also came increased confidence and time savings for the business teams.

Mujoo commented, “One submission team manager told me ‘Before, I was not able to sleep, thinking I may have missed something, but now I have my sleep back. And each of my team members is able to save one hour every day.’”

VISIBILITY AND DATA EXPLORATION FOR EVERYONEWith widespread adoption of Spotfire analytics, all teams are collaborating and finding similarities in common data. Exploratory data analysis and working with data becomes fast and easy for everyone. “Everybody is looking at a different view of the same data, like a Rubik’s cube, bringing them closer and helping them to collaborate,” said Mujoo. “We’re able to refresh the data and see live data as and when it happens. That’s something that delights users.”

Mujoo’s team uses Spotfire analytics for real-time analysis of case data, tracking changes and updates quickly and easily. “I see Spotfire analytics as something that is integrating our department,” said Mujoo. “The KPI chart is quite popular because it creates a nice dashboard for trends, and then users can drill down for more details. Under the hood may be multiple data sources, but for end users, it is single source of information.”

With IronPython script, Gilead also has the ability to automate and customize dashboards to meet groups’ needs in a simple and efficient way.

ANALYTICS ON ANALYTICS“We never had any kind of dashboard to measure resource productivity, but with Spotfire analytics, we have the ability to get quantitative attributes like number of submissions or cases processed by a group or user. We can even view workload peak months or weeks,” said Mujoo. By creating a dashboard, the team can see day-to-day operational data and compare it to historical trends. If a case stays longer than usual in a particular workflow, it can pointed out as an outlier, and the group or user responsible can identify the root cause.

FUTUREGilead’s goals include automation, artificial intelligence, and accelerated use of the Spotfire solution. “We are looking forward to TIBCO® Data Virtualization to add more data sources. We are also looking at adding machine learning and AI capabilities to increase use of Spotfire analytics in other groups,” said Mujoo.

ABOUT Gilead is a research-based biopharmaceutical company that discovers, develops, and commercializes medicines for unmet medical needs. With over 25 products and an active R&D program, Gilead is committed to ensuring global access and to focusing on the therapeutic areas of HIV/AIDS, liver diseases, hematology/oncology, and inflammatory diseases.

RESULTS

•  1,500% increase in report usage, supporting broader organizational intelligence

•  Report build time reduced from years to months

•  Interactive dashboards with absolutely zero maintenance

•  50x reduction in number of reports, consolidated view resulting in a single source of truth